Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NanoDex

NanoDex
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a drug researching platform designed to focus on preparing cancer drugs. The company's drug researching platform offers a cyclodextrin-based nanocarrier to treat the cells affected by cancer, enabling patients to get recovery from early stages of cancer.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Delivery
Primary Office
  • Kanagawa Industrial Technical Center
  • 1st Floor, 1-2, 705-1 Imaizumi
  • Ebina, Kanagawa 243-0435
  • Japan

+81 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NanoDex’s full profile, request a free trial.

NanoDex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NanoDex Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Whiz Partners Asset Manager Minority 000 0000 000000 0

NanoDex Executive Team (1)

Name Title Board
Seat
Contact
Info
Kenjiro Hattori President & Board Member

NanoDex Board Members (1)

Name Representing Role Since Contact
Info
Kenjiro Hattori NanoDex President & Board Member 000 0000